InsiderClue
Stocks · Health care · Pharmaceutical Preparations

CytomX Therapeutics, Inc.

CTMX Clue Score50
United States Fiscal year ends December CIK 0001501989 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

164
Insider
Date
Role
Action
Shares
Price
Amount
Christopher Ogden
15 Jun 2026
Chief Financial Officer
Sell
1,624
$3.05
$4.95K
Christopher Ogden
17 Mar 2026
Chief Financial Officer
Sell
19,323
$6.42
$124.11K
Marcia Belvin
17 Mar 2026
SVP, Chief Scientific Officer
Sell
31,492
$6.42
$202.27K
Sean A. McCarthy
17 Mar 2026
CEO
Sold on a plan
118,969
$6.42
$764.14K
Yu-Waye Chu
17 Mar 2026
Chief Medical Officer
Sell
21,279
$6.42
$136.68K
Sean A. McCarthy
6 Nov 2025
CEO
Sold on a plan
101,793
$4.54
$461.91K
Sean A. McCarthy
16 Jun 2025
CEO
Sell
55,511
$2.69
$149.26K
Marcia Belvin
16 Jun 2025
SVP, Chief Scientific Officer
Sell
13,884
$2.69
$37.33K
Christopher Ogden
16 Jun 2025
Chief Financial Officer
Sell
10,614
$2.69
$28.54K
Christopher Ogden
13 Jun 2025
Chief Financial Officer
Sold after exercise
1,641
$2.95
$4.84K
Marcia Belvin
18 Mar 2025
SVP, Chief Scientific Officer
Sell
19,512
$0.60
$11.69K
Lloyd A Rowland
18 Mar 2025
General Counsel
Sell
10,203
$0.60
$6.11K
Yu-Waye Chu
18 Mar 2025
Chief Medical Officer
Sell
4,025
$0.60
$2.41K
Christopher Ogden
18 Mar 2025
Chief Financial Officer
Sell
8,551
$0.60
$5.12K
Sean A. McCarthy
18 Mar 2025
CEO
Sell
37,656
$0.60
$22.56K
Sean A. McCarthy
20 Aug 2024
CEO
Sold after exercise
13,898
$1.23
$17.08K
Christopher Ogden
20 Aug 2024
Chief Financial Officer
Sold after exercise
1,984
$1.23
$2.44K
Lloyd A Rowland
20 Aug 2024
General Counsel
Sold after exercise
4,181
$1.23
$5.14K
Marcia Belvin
20 Aug 2024
SVP, Chief Scientific Officer
Sold after exercise
4,181
$1.23
$5.14K
Jeffrey B Landau
20 Aug 2024
Chief Business Officer
Sold after exercise
4,181
$1.23
$5.14K
Sean A. McCarthy
26 Mar 2024
CEO
Exercised, kept
109,768
$1.57
$172.87K
Jeffrey B Landau
19 Mar 2024
Chief Business Officer
Sell
6,562
$2.09
$13.69K
Marcia Belvin
19 Mar 2024
SVP, Chief Scientific Officer
Sell
12,795
$2.09
$26.68K
Christopher Ogden
19 Mar 2024
SVP, Finance and Accounting
Sell
2,971
$2.09
$6.20K
Sean A. McCarthy
19 Mar 2024
CEO
Sell
20,223
$2.09
$42.18K
Lloyd A Rowland
19 Mar 2024
General Counsel
Sell
5,268
$2.09
$10.99K
Christopher Ogden
20 Dec 2023
SVP, Finance and Accounting
Sell
1,990
$1.38
$2.75K
Lloyd A Rowland
20 Dec 2023
General Counsel
Sell
4,077
$1.38
$5.63K
Jeffrey B Landau
20 Dec 2023
Chief Business Officer
Sell
4,077
$1.38
$5.63K
Marcia Belvin
20 Dec 2023
SVP, Chief Scientific Officer
Sell
4,077
$1.38
$5.63K
Sean A. McCarthy
20 Dec 2023
CEO
Sell
13,551
$1.38
$18.71K
Lloyd A Rowland
22 Sep 2023
General Counsel
Sell
5,486
$1.30
$7.14K
Sean A. McCarthy
22 Sep 2023
CEO
Sell
14,601
$1.30
$18.99K
Jeffrey B Landau
22 Sep 2023
Chief Business Officer
Sell
4,119
$1.30
$5.36K
Marcia Belvin
22 Sep 2023
SVP, Chief Scientific Officer
Sell
4,119
$1.30
$5.36K
Sean A. McCarthy
19 May 2023
CEO
Exercised, kept
16,535
$1.57
$26.04K
Elaine Jones V
29 Mar 2023
Director
Buy
5,000
$1.55
$7.75K
Amy C. Peterson
16 Mar 2023
EVP, Chief Development Officer
Sell
4,257
$1.98
$8.42K
Jeffrey B Landau
16 Mar 2023
Chief Financial Officer
Sell
1,477
$1.98
$2.92K
Lloyd A Rowland
16 Mar 2023
General Counsel
Sell
2,037
$1.98
$4.03K
Carlos Campoy
16 Mar 2023
Chief Financial Officer
Sell
1,748
$1.98
$3.46K
Sean A. McCarthy
16 Mar 2023
CEO
Sell
7,121
$1.88
$13.39K
Christopher Ogden
16 Mar 2023
SVP, Finance and Accounting
Sell
516
$1.98
$1.02K
Carlos Campoy
20 Jul 2022
Chief Financial Officer
Sell
3,949
$1.42
$5.62K
Alison L. Hannah
20 Jul 2022
Chief Medical Officer
Sell
5,602
$1.42
$7.97K
Lloyd A Rowland
20 Jul 2022
General Counsel
Sell
5,602
$1.42
$7.97K
Sean A. McCarthy
20 Jul 2022
President and CEO
Sell
14,911
$1.42
$21.21K
Jeffrey B Landau
20 Jul 2022
Chief Business Officer
Sell
4,206
$1.42
$5.98K
Amy C. Peterson
20 Jul 2022
EVP, Chief Development Officer
Sell
7,463
$1.42
$10.61K
Sean A. McCarthy
9 May 2022
President and CEO
Exercised, kept
24,189
$0.95
$22.86K
Sean A. McCarthy
9 May 2022
President and CEO
Exercised, kept
66,742
$0.95
$63.07K
Sean A. McCarthy
11 Aug 2021
President and CEO
Exercised, kept
92,113
$1.13
$104.45K
Sean A. McCarthy
16 Jun 2021
President and CEO
Sell indirect
100,000
$7.04
$704.47K
Sean A. McCarthy
14 Jun 2021
President and CEO
Exercised, kept
10
$0.95
$9.45
Sean A. McCarthy
14 Jun 2021
President and CEO
Exercised, kept
30
$1.13
$34.02
Sean A. McCarthy
31 Mar 2021
President and CEO
Sold after exercise
100,000
$7.49
$749.47K
Sean A. McCarthy
23 Dec 2020
President and CEO
Exercised, kept
100,000
$1.13
$113.39K
Sean A. McCarthy
21 Sep 2020
President and CEO
Exercised, kept
20,500
$6.61
$135.60K
Sean A. McCarthy
12 May 2020
President and CEO
Sold after exercise
36,000
$15.00
$540.00K
Lloyd A Rowland
4 Mar 2019
General Counsel
Buy
9,000
$10.33
$92.97K
Debanjan Ray
12 Dec 2018
Chief Financial Officer
Sold after exercise
3,000
$15.00
$45.00K
Sean A. McCarthy
2 Nov 2018
President and CEO
Sold after exercise
1,156
$15.01
$17.35K
Sean A. McCarthy
1 Nov 2018
President and CEO
Sold after exercise
5,270
$15.00
$79.05K
Sean A. McCarthy
1 Nov 2018
President and CEO
Sold after exercise
100
$15.01
$1.50K
Debanjan Ray
1 Nov 2018
Chief Financial Officer
Sold after exercise
3,000
$15.00
$45.00K
Debanjan Ray
1 Oct 2018
Chief Financial Officer
Sold after exercise
3,000
$18.46
$55.38K
Sean A. McCarthy
4 Sep 2018
President and CEO
Sold after exercise
13,052
$21.86
$285.34K
Debanjan Ray
4 Sep 2018
Chief Financial Officer
Sold after exercise
3,000
$22.39
$67.17K
Debanjan Ray
1 Aug 2018
Chief Financial Officer
Sold after exercise
3,000
$26.05
$78.15K
Sean A. McCarthy
5 Jul 2018
President and CEO
Sold after exercise
4,497
$25.06
$112.69K
Sean A. McCarthy
3 Jul 2018
President and CEO
Sold after exercise
2,028
$25.09
$50.88K
Sean A. McCarthy
2 Jul 2018
President and CEO
Sold after exercise
13,052
$23.42
$305.71K
Debanjan Ray
2 Jul 2018
Chief Financial Officer
Sold after exercise
3,000
$22.56
$67.68K
Debanjan Ray
1 Jun 2018
Chief Financial Officer
Sold after exercise
3,000
$25.93
$77.79K
Sean A. McCarthy
1 May 2018
President and CEO
Sold after exercise
19,578
$26.55
$519.74K
Debanjan Ray
1 May 2018
Chief Financial Officer
Sold after exercise
3,000
$26.52
$79.56K
Debanjan Ray
2 Apr 2018
Chief Financial Officer
Sold after exercise
3,000
$28.12
$84.36K
Frederick W Gluck
26 Mar 2018
Director
Sell indirect
5,000
$31.93
$159.64K
Debanjan Ray
2 Mar 2018
Chief Financial Officer
Sold after exercise
1,944
$31.02
$60.29K
Debanjan Ray
2 Mar 2018
Chief Financial Officer
Sold after exercise
12,541
$30.41
$381.38K
Debanjan Ray
2 Mar 2018
Chief Financial Officer
Sold after exercise
5,515
$30.06
$165.78K
Rachel Humphrey
2 Mar 2018
Chief Medical Officer
Sold after exercise
16,160
$30.00
$484.80K
Frederick W Gluck
2 Mar 2018
Director
Sell indirect
16,181
$30.00
$485.47K
Sean A. McCarthy
1 Mar 2018
President and CEO
Sold after exercise
19,578
$29.43
$576.14K
Debanjan Ray
1 Mar 2018
Chief Financial Officer
Sold after exercise
13,000
$29.40
$382.24K
Frederick W Gluck
28 Feb 2018
Director
Sell indirect
3,819
$30.00
$114.57K
Rachel Humphrey
28 Feb 2018
Chief Medical Officer
Sold after exercise
23,840
$30.00
$715.20K
Debanjan Ray
1 Feb 2018
Chief Financial Officer
Sell
2,548
$26.69
$68.01K
Frederick W Gluck
5 Jan 2018
Director
Sell indirect
10,000
$25.01
$250.08K
Sean A. McCarthy
5 Jan 2018
President and CEO
Sold after exercise
6,526
$25.01
$163.22K
Debanjan Ray
2 Jan 2018
Chief Financial Officer
Sell
2,500
$21.11
$52.78K
Sean A. McCarthy
2 Jan 2018
President and CEO
Sold after exercise
13,052
$21.04
$274.61K
Frederick W Gluck
26 Dec 2017
Director
Sell indirect
5,000
$22.29
$111.43K
Rachel Humphrey
15 Dec 2017
Chief Medical Officer
Exercised, kept
15,117
$6.61
$99.99K
William Michael Kavanaugh
8 Dec 2017
CSO, Head Res.&Non-Clin. Dev.
Exercised, kept
5,130
$1.57
$8.08K
Sean A. McCarthy
1 Dec 2017
President and CEO
Sold after exercise
14,340
$20.60
$295.40K
Debanjan Ray
1 Dec 2017
Chief Financial Officer
Sell
2,500
$20.58
$51.45K
Debanjan Ray
1 Nov 2017
Chief Financial Officer
Sell
2,500
$20.00
$50.00K
Sean A. McCarthy
1 Nov 2017
President and CEO
Sold after exercise
14,342
$19.86
$284.83K
Robert I Tepper
4 Oct 2017
10% owner
Sell
24,777
$24.34
$603.07K
Frederick W Gluck
4 Oct 2017
Director
Sell indirect
10,000
$24.27
$242.68K
William Michael Kavanaugh
4 Oct 2017
CSO, Head Res.&Non-Clin. Dev.
Sold after exercise
48,368
$24.34
$1.18M
Sean A. McCarthy
4 Oct 2017
President and CEO
Sold after exercise
19,120
$24.13
$461.37K
Debanjan Ray
2 Oct 2017
Chief Financial Officer
Sell
2,500
$18.10
$45.25K
Sean A. McCarthy
2 Oct 2017
President and CEO
Sold after exercise
9,562
$18.57
$177.57K
Frederick W Gluck
26 Sep 2017
Director
Sell indirect
5,000
$17.30
$86.48K
Robert I Tepper
19 Sep 2017
10% owner
Sell
20,000
$18.00
$360.00K
Sean A. McCarthy
1 Sep 2017
President and CEO
Sold after exercise
9,930
$17.32
$171.99K
Debanjan Ray
1 Sep 2017
Chief Financial Officer
Sell
2,500
$17.17
$42.93K
Sean A. McCarthy
31 Aug 2017
President and CEO
Sold after exercise
3,000
$17.51
$52.53K
Sean A. McCarthy
31 Aug 2017
President and CEO
Sold after exercise
15,756
$17.50
$275.73K
Sean A. McCarthy
9 Aug 2017
President and CEO
Sold after exercise
4,781
$15.00
$71.72K
Debanjan Ray
9 Aug 2017
Chief Financial Officer
Sell
2,500
$15.00
$37.50K
Debanjan Ray
3 Jul 2017
Chief Financial Officer
Sell
2,500
$15.47
$38.68K
Sean A. McCarthy
3 Jul 2017
President and CEO
Sold after exercise
4,781
$15.52
$74.20K
Robert I Tepper
29 Jun 2017
10% owner
Sell
15,000
$16.00
$240.00K
Sean A. McCarthy
26 Jun 2017
President and CEO
Sold after exercise
4,481
$15.00
$67.22K
Frederick W Gluck
26 Jun 2017
Director
Sell indirect
5,000
$14.61
$73.05K
Sean A. McCarthy
5 Jun 2017
President and CEO
Sold after exercise
300
$15.00
$4.50K
II Robert C. Goeltz
12 May 2017
Chief Financial Officer
Exercised, kept
9,987
$6.61
$66.06K
II Robert C. Goeltz
12 May 2017
Chief Financial Officer
Exercised, kept
9,980
$4.47
$44.64K
Sean A. McCarthy
1 May 2017
President and CEO
Sold after exercise
4,781
$15.70
$75.06K
Kevin P Starr
12 Apr 2017
10% owner
Sell
28,357
$16.36
$463.79K
II Robert C. Goeltz
10 Apr 2017
Chief Financial Officer
Exercised, kept
3,000
$4.47
$13.42K
Sean A. McCarthy
4 Apr 2017
President and CEO
Sold after exercise
4,781
$17.50
$83.67K
Sean A. McCarthy
3 Apr 2017
President and CEO
Sold after exercise
4,781
$16.94
$80.99K
Neil Exter
27 Mar 2017
Director
Sell indirect
0
$0.00
$0.00
Third Rock Ventures LP
27 Mar 2017
10% owner
Sell
650,000
$18.00
$11.70M
Neil Exter
23 Mar 2017
Director
Sell indirect
0
$0.00
$0.00
Third Rock Ventures LP
23 Mar 2017
10% owner
Sell
1,000,000
$17.00
$17.00M
Sean A. McCarthy
20 Mar 2017
President and CEO
Sold after exercise
14,343
$19.60
$281.12K
II Robert C. Goeltz
20 Mar 2017
Chief Financial Officer
Sold after exercise
11,517
$20.00
$230.34K
II Robert C. Goeltz
20 Mar 2017
Chief Financial Officer
Sold after exercise
10,000
$19.60
$196.00K
II Robert C. Goeltz
9 Mar 2017
Chief Financial Officer
Exercised, kept
2,500
$4.47
$11.18K
Sean A. McCarthy
3 Mar 2017
President and CEO
Sold after exercise
14,343
$15.00
$215.15K
Rachel Humphrey
28 Dec 2016
Chief Medical Officer
Exercised, kept
15,117
$6.61
$99.99K
Canaan IX L.P.
29 Nov 2016
Director
Sell indirect
22,086
$11.18
$247.01K
Timothy M Shannon
29 Nov 2016
Director
Sell indirect
22,086
$11.18
$247.01K
Canaan IX L.P.
28 Nov 2016
Director
Sell indirect
20,840
$11.33
$236.14K
Timothy M Shannon
28 Nov 2016
Director
Sell indirect
20,840
$11.33
$236.14K
Canaan IX L.P.
25 Nov 2016
Director
Sell indirect
6,729
$11.79
$79.34K
Timothy M Shannon
25 Nov 2016
Director
Sell indirect
6,729
$11.79
$79.34K
Canaan IX L.P.
23 Nov 2016
Director
Sell indirect
10,890
$11.84
$128.92K
Timothy M Shannon
23 Nov 2016
Director
Sell indirect
10,890
$11.84
$128.92K
Canaan IX L.P.
22 Nov 2016
Director
Sell indirect
42,550
$11.71
$498.08K
Timothy M Shannon
22 Nov 2016
Director
Sell indirect
42,550
$11.71
$498.08K
Canaan IX L.P.
21 Nov 2016
Director
Sell indirect
13,548
$11.72
$158.79K
Timothy M Shannon
21 Nov 2016
Director
Sell indirect
13,548
$11.72
$158.79K
Canaan IX L.P.
18 Nov 2016
Director
Sell indirect
12,805
$11.64
$149.08K
Timothy M Shannon
18 Nov 2016
Director
Sell indirect
12,805
$11.64
$149.08K
Canaan IX L.P.
17 Nov 2016
Director
Sell indirect
18,971
$11.50
$218.22K
Timothy M Shannon
17 Nov 2016
Director
Sell indirect
18,971
$11.50
$218.22K
Canaan IX L.P.
16 Nov 2016
Director
Sell indirect
18,517
$11.55
$213.95K
Timothy M Shannon
16 Nov 2016
Director
Sell indirect
18,517
$11.55
$213.95K
Canaan IX L.P.
15 Nov 2016
Director
Sell indirect
33,064
$11.48
$379.48K
Timothy M Shannon
15 Nov 2016
Director
Sell indirect
33,064
$11.48
$379.48K
Canaan IX L.P.
14 Nov 2016
Director
Sell indirect
23,744
$11.21
$266.06K
Timothy M Shannon
14 Nov 2016
Director
Sell indirect
23,744
$11.21
$266.06K
Canaan IX L.P.
11 Nov 2016
Director
Sell indirect
35,391
$11.20
$396.46K
Timothy M Shannon
11 Nov 2016
Director
Sell indirect
35,391
$11.20
$396.46K
Canaan IX L.P.
10 Nov 2016
Director
Sell indirect
27,135
$11.07
$300.39K
Timothy M Shannon
10 Nov 2016
Director
Sell indirect
27,135
$11.07
$300.39K
Canaan IX L.P.
9 Nov 2016
Director
Sell indirect
13,730
$11.03
$151.50K
Timothy M Shannon
9 Nov 2016
Director
Sell indirect
13,730
$11.03
$151.50K

What was left out

Form 4 filings counted 311
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 53
Sales at will 91
Transactions with no price 0
Shares from compensation/vesting 8,432,272
Sales filed before the plan box existed 59
History held since 9 Oct 2015